2011
DOI: 10.1177/0300985811417249
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of Immune Cell Infiltration Into Canine Intracranial Meningiomas

Abstract: Meningiomas are the most common intracranial tumors in dogs. A variety of inflammatory cells have been shown to invade these tumors in people, but little is known about interactions between the immune system and naturally occurring brain tumors in dogs. The purpose of this study was to investigate the presence of a variety of immune cell subsets within canine intracranial meningiomas. Twenty-three formalin-fixed, paraffin-embedded tumor samples were evaluated using immunohistochemistry with antibodies specific… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
20
0

Year Published

2013
2013
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(21 citation statements)
references
References 68 publications
0
20
0
Order By: Relevance
“…Several “vaccine”‐based approaches have been developed including vaccination with patient dendritic cells “primed” with tumor antigen, tumor peptides, heat shock proteins, and autologous and allogenic tumor cell preparations 203, 230, 231, 232, 233. Limited information is available defining immune cell activity in canine brain tumors, but preliminary studies defining immune cell infiltration in canine meningiomas,234 and the ability of Flt3L to stimulate canine dendritic cells,235 suggest that there will be many similarities to human tumors. Translational studies in dogs with glioma using tumor cell lysate/CpG vaccines, combined with postsurgical intracavitary delivery of IFNg via an adenoviral vector, have demonstrated the feasibility of immunotherapy in dogs, with tumor‐reactive IgG and CD8+ T cells being documented in 1 reported case 206, 236.…”
Section: Novel Therapiesmentioning
confidence: 99%
“…Several “vaccine”‐based approaches have been developed including vaccination with patient dendritic cells “primed” with tumor antigen, tumor peptides, heat shock proteins, and autologous and allogenic tumor cell preparations 203, 230, 231, 232, 233. Limited information is available defining immune cell activity in canine brain tumors, but preliminary studies defining immune cell infiltration in canine meningiomas,234 and the ability of Flt3L to stimulate canine dendritic cells,235 suggest that there will be many similarities to human tumors. Translational studies in dogs with glioma using tumor cell lysate/CpG vaccines, combined with postsurgical intracavitary delivery of IFNg via an adenoviral vector, have demonstrated the feasibility of immunotherapy in dogs, with tumor‐reactive IgG and CD8+ T cells being documented in 1 reported case 206, 236.…”
Section: Novel Therapiesmentioning
confidence: 99%
“…In the brain of different species including humans and laboratory rodents TLR4 expression has been reported in microglia and astrocytes with microglia exhibiting higher expression rates [27]. In the canine brain TLR4 expression has so far only been analyzed in tissue surrounding intracranial meningiomas [28]. The authors described scattered TLR4-expressing macrophages in the area of the tumor-brain interface [28].…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, immunohistochemistry gave no evidence to suggest that the cells were neoplastic cells from the ependym. Boozer et al (2012) investigated the presence of a variety of immune cell subsets within canine intracranial meningiomas. They demonstrated that immune cell infiltration was evident in all samples, with a predominance of CD3 + T cells.…”
Section: Discussionmentioning
confidence: 99%